Allan I. Levey
#90,194
Most Influential Person Now
Allan I. Levey's AcademicInfluence.com Rankings
Allan I. Leveymedical Degrees
Medical
#937
World Rank
#1207
Historical Rank
Neurology
#79
World Rank
#128
Historical Rank

Download Badge
Medical
Why Is Allan I. Levey Influential?
(Suggest an Edit or Addition)Allan I. Levey's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (Ch1–Ch6) (1983) (2258)
- Variant of TREM2 associated with the risk of Alzheimer's disease. (2013) (2004)
- Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey (1983) (1880)
- Vitamin E and donepezil for the treatment of mild cognitive impairment. (2005) (1712)
- Localization of neuronal and glial glutamate transporters (1994) (1689)
- Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) (1656)
- Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo (1996) (1492)
- Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis (1995) (1464)
- Analysis of shared heritability in common disorders of the brain (2016) (1385)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (1073)
- Endoproteolysis of Presenilin 1 and Accumulation of Processed Derivatives In Vivo (1996) (1061)
- A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction (2007) (1013)
- Distribution of cholinergic neurons in rat brain: Demonstrated by the immunocytochemical localization of choline acetyltransferase (1983) (960)
- A common variant on chromosome 9p21 affects the risk of myocardial infarction. (2007) (795)
- Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction (2009) (790)
- The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm (2008) (765)
- 5-hmC–mediated epigenetic dynamics during postnatal neurodevelopment and aging (2011) (750)
- Striatal dopamine nerve terminal markers in human, chronic methamphetamine users (1996) (730)
- Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis (2016) (716)
- Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease (2017) (693)
- Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report (2019) (646)
- Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. (1993) (616)
- AMPA glutamate receptor subunits are differentially distributed in rat brain (1993) (597)
- The origins of cholinergic and other subcortical afferents to the thalamus in the rat (1987) (595)
- Dopamine Axon Varicosities in the Prelimbic Division of the Rat Prefrontal Cortex Exhibit Sparse Immunoreactivity for the Dopamine Transporter (1998) (583)
- Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry (1984) (568)
- Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease. (1997) (562)
- Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine (2002) (546)
- Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: Light and electron microscopy (1995) (527)
- Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases* (2004) (522)
- Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions (2010) (475)
- D1 and D2 dopamine receptor mRNA in rat brain. (1991) (475)
- Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. (1990) (448)
- Oxidative Damage of DJ-1 Is Linked to Sporadic Parkinson and Alzheimer Diseases* (2006) (448)
- Implanted neural electrodes cause chronic, local inflammation that is correlated with local neurodegeneration (2009) (433)
- Immunological localization of m1-m5 muscarinic acetylcholine receptors in peripheral tissues and brain. (1993) (426)
- Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons (2000) (424)
- Activation of Metabotropic Glutamate Receptor 5 Has Direct Excitatory Effects and Potentiates NMDA Receptor Currents in Neurons of the Subthalamic Nucleus (2000) (415)
- D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. (1994) (396)
- A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction (2006) (383)
- Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation (2019) (372)
- Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. (1997) (370)
- Co-localization of acetylcholinesterase and choline acetyltransferase in the rat cerebrum (1983) (362)
- Dopamine transporters and neuronal injury. (1999) (359)
- Functional Interaction between Monoamine Plasma Membrane Transporters and the Synaptic PDZ Domain–Containing Protein PICK1 (2001) (345)
- Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease. (1996) (330)
- Immunocytochemical localization of the dopamine transporter in human brain (1999) (328)
- Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer’s disease (2014) (317)
- Identification and localization of huntingtin in brain and human lymphoblastoid cell lines with anti-fusion protein antibodies. (1995) (317)
- Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis (2012) (308)
- Characterization of Central Inhibitory Muscarinic Autoreceptors by the Use of Muscarinic Acetylcholine Receptor Knock-Out Mice (2002) (306)
- Loss of apolipoprotein E receptor LR11 in Alzheimer disease. (2004) (304)
- Cholinergic and non-cholinergic septohippocampal pathways (1985) (303)
- Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra (1997) (298)
- Variant of TREM 2 Associated with the Risk of Alzheimer ’ s Disease (2012) (296)
- A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer's Disease. (2017) (286)
- Cholinergic systems in mammalian brain identified with antibodies against choline acetyltransferase (1984) (284)
- Age‐related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys (1998) (280)
- Choline acetyltransferase-immunoreactive neurons intrinsic to rodent cortex and distinction from acetylcholinesterase-positive neurons (1984) (279)
- Oxidative Modifications and Aggregation of Cu,Zn-Superoxide Dismutase Associated with Alzheimer and Parkinson Diseases* (2005) (278)
- Muscarinic acetylcholine receptor subtypes in cerebral cortex and hippocampus. (2004) (276)
- The Lipoprotein Receptor LR11 Regulates Amyloid β Production and Amyloid Precursor Protein Traffic in Endosomal Compartments (2006) (276)
- Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease (2015) (275)
- Common variants at MS 4 A 4 / MS 4 A 6 E , CD 2 AP , CD 33 and EPHA 1 are associated with late-onset Alzheimer ’ s disease (2011) (274)
- Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells. (1998) (272)
- Familial Parkinson's Disease-associated L166P Mutation Disrupts DJ-1 Protein Folding and Function* (2004) (268)
- Substance P-Containing terminals in synaptic contact with cholinergic neurons in the neostriatum and basal forebrain: a double immunocytochemical study in the rat (1986) (268)
- Monoclonal antibodies to choline acetyltransferase: production, specificity, and immunohistochemistry (1983) (265)
- Dopaminergic Neurons Intrinsic to the Primate Striatum (1997) (262)
- Proteomic Characterization of Postmortem Amyloid Plaques Isolated by Laser Capture Microdissection*[boxs] (2004) (260)
- Evidence for brain glucose dysregulation in Alzheimer's disease (2018) (258)
- Association of m1 and m2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex: morphological evidence for cholinergic modulation of excitatory neurotransmission. (1993) (247)
- The Mount Sinai cohort of large-scale genomic, transcriptomic and proteomic data in Alzheimer's disease (2018) (242)
- Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease (1999) (241)
- RGS2 Binds Directly and Selectively to the M1 Muscarinic Acetylcholine Receptor Third Intracellular Loop to Modulate Gq/11α Signaling* (2004) (240)
- A light and electron microscopic procedure for sequential double antigen localization using diaminobenzidine and benzidine dihydrochloride. (1986) (239)
- U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer’s disease (2013) (236)
- Biochemical Characterization and Localization of a Non‐N‐Methyl‐D‐Aspartate Glutamate Receptor in Rat Brain (1992) (231)
- Novel Selective Allosteric Activator of the M1 Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in Rats (2008) (228)
- Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease (1996) (224)
- A Selective Allosteric Potentiator of the M1 Muscarinic Acetylcholine Receptor Increases Activity of Medial Prefrontal Cortical Neurons and Restores Impairments in Reversal Learning (2009) (221)
- Differential Regulation of Molecular Subtypes of Muscarinic Receptors in Alzheimer's Disease (1995) (220)
- Vesicular Localization and Activity-Dependent Trafficking of Presynaptic Choline Transporters (2003) (215)
- The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine (2004) (214)
- Distinct interneuron types express m2 muscarinic receptor immunoreactivity on their dendrites or axon terminals in the hippocampus (1997) (213)
- Complex relationship between Parkin mutations and Parkinson disease. (2002) (212)
- Loss of basal forebrain P75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease (2002) (209)
- Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. (2012) (208)
- Dopamine D5 receptor immunolocalization in rat and monkey brain (2000) (206)
- Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease (2016) (202)
- Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology (2016) (201)
- Cholinergic nucleus basalis neurons may influence the cortex via the thalamus (1987) (200)
- Four distinct trajectories of tau deposition identified in Alzheimer’s disease (2021) (200)
- Immunochemical analysis of dopamine transporter protein in Parkinson's disease (1997) (197)
- Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm (2010) (197)
- Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease (2018) (196)
- Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2019) (194)
- Tau pathology in a family with dementia and a P301L mutation in tau. (1999) (187)
- Elevated serum pesticide levels and risk for Alzheimer disease. (2014) (185)
- Immunochemical Analysis of Vesicular Monoamine Transporter (VMAT2) Protein in Parkinson's Disease (1999) (183)
- Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer's disease (2015) (183)
- Increased MPTP Neurotoxicity in Vesicular Monoamine Transporter 2 Heterozygote Knockout Mice (1998) (179)
- Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease. (2006) (177)
- Immunological detection of muscarinic receptor subtype proteins (m1-m5) in rabbit peripheral tissues. (1991) (174)
- Autosomal recessive causes likely in early-onset Alzheimer disease. (2012) (172)
- Light and Electron Microscopic Localization of Presenilin-1 in Primate Brain (1997) (172)
- Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users (1996) (171)
- Polyubiquitin Linkage Profiles in Three Models of Proteolytic Stress Suggest the Etiology of Alzheimer Disease* (2011) (169)
- Glycogen synthase kinase 3β and Alzheimer’s disease: pathophysiological and therapeutic significance (2006) (167)
- Immunohistochemical localization of subtype 4a metabotropic glutamate receptors in the rat and mouse basal ganglia (1999) (166)
- Localization of metabotropic glutamate receptor 7 mRNA and mGluR7a protein in the rat basal ganglia (1999) (164)
- Cholinergic vs. noncholinergic efferents from the mesopontine tegmentum to the extrapyramidal motor system nuclei (1988) (164)
- Differential expression of D1 and D2 dopamine and m4 muscarinic acetylcholine receptor proteins in identified striatonigral neurons (1997) (163)
- Role of Presynaptic Muscarinic and GABAB Receptors in Spinal Glutamate Release and Cholinergic Analgesia in Rats (2002) (162)
- Ferritin levels in the cerebrospinal fluid predict Alzheimer's disease outcomes and are regulated by APOE (2015) (161)
- Microengineered human blood–brain barrier platform for understanding nanoparticle transport mechanisms (2020) (159)
- Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. (2012) (158)
- Hyperaccumulation of FAD-linked presenilin 1 variants in vivo (1997) (147)
- Alterations in Glutamate Transporter Protein Levels in Kindling‐Induced Epilepsy (1997) (146)
- Proteomic identification of novel proteins associated with Lewy bodies. (2008) (145)
- Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice. (2002) (145)
- Rab11a and Myosin Vb Regulate Recycling of the M4Muscarinic Acetylcholine Receptor (2002) (144)
- Localization of muscarinic M3 receptor protein and M3 receptor binding in rat brain (1994) (143)
- Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers. (2012) (140)
- Meta-Analysis of the Alzheimer’s Disease Human Brain Transcriptome and Functional Dissection in Mouse Models (2020) (140)
- Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study. (2014) (140)
- A Meta-Analysis of Alzheimer's Disease Incidence and Prevalence Comparing African-Americans and Caucasians. (2015) (139)
- Activation of Group II Metabotropic Glutamate Receptors Inhibits Synaptic Excitation of the Substantia Nigra Pars Reticulata (2000) (138)
- Predicting Alzheimer’s disease progression using multi-modal deep learning approach (2019) (136)
- LR11/SorLA Expression Is Reduced in Sporadic Alzheimer Disease but not in Familial Alzheimer Disease (2006) (135)
- Chapter 5 Cholinergic innervation and receptors in the cerebellum (1997) (135)
- Global quantitative analysis of the human brain proteome in Alzheimer’s and Parkinson’s Disease (2018) (135)
- Choline acetyltransferase immunoreactivity in the rat thalamus (1987) (134)
- Pre- and postsynaptic localization of GABAB receptors in the basal ganglia in monkeys (1999) (131)
- A Subpopulation of Neuronal M4 Muscarinic Acetylcholine Receptors Plays a Critical Role in Modulating Dopamine-Dependent Behaviors (2010) (126)
- Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid‐β oligomers (2010) (126)
- Light and electron microscopic study of m2 muscarinic acetylcholine receptor in the basal forebrain of the rat (1995) (125)
- Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease (2013) (125)
- Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics. (2010) (125)
- Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease (2018) (123)
- Loss of LR11/SORLA Enhances Early Pathology in a Mouse Model of Amyloidosis: Evidence for a Proximal Role in Alzheimer's Disease (2008) (122)
- TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions (2014) (119)
- Cell-specific Sorting of Biogenic Amine Transporters Expressed in Epithelial Cells* (1996) (119)
- TREM2 is associated with increased risk for Alzheimer’s disease in African Americans (2015) (116)
- Eye Tracking During a Visual Paired Comparison Task as a Predictor of Early Dementia (2009) (115)
- The zinc transporter ZnT3 interacts with AP-3 and it is preferentially targeted to a distinct synaptic vesicle subpopulation. (2003) (114)
- Deletion of M1 Muscarinic Acetylcholine Receptors Increases Amyloid Pathology In Vitro and In Vivo (2010) (114)
- Subcellular Redistribution of m2 Muscarinic Acetylcholine Receptors in Striatal Interneurons In Vivo after Acute Cholinergic Stimulation (1998) (112)
- Nigrostriatal collaterals to thalamus degenerate in parkinsonian animal models (2001) (111)
- Muscarinic m1 and m2 receptor proteins in local circuit and projection neurons of the primate striatum: Anatomical evidence for cholinergic modulation of glutamatergic prefronto‐striatal pathways (2001) (109)
- Multiple Effects of Aspartate Mutant Presenilin 1 on the Processing and Trafficking of Amyloid Precursor Protein* (2001) (109)
- Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease. (2016) (108)
- Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities (2007) (107)
- Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age (2019) (106)
- Pharmacologic Inhibition of ROCK2 Suppresses Amyloid-β Production in an Alzheimer's Disease Mouse Model (2013) (106)
- A proteomic network approach across the ALS‐FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain (2017) (105)
- Cellular and subcellular localization of the dopamine transporter in rat cortex. (1998) (105)
- Interaction of Akt-phosphorylated SRPK2 with 14-3-3 Mediates Cell Cycle and Cell Death in Neurons* (2009) (105)
- Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases (2012) (104)
- Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer’s disease pathogenesis (2021) (103)
- Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach. (2014) (103)
- Neuronal LR11/sorLA expression is reduced in mild cognitive impairment (2007) (102)
- Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease (2019) (101)
- Muscarinic receptor subtypes involved in hippocampal circuits. (1999) (100)
- Coaggregation of RNA-Binding Proteins in a Model of TDP-43 Proteinopathy with Selective RGG Motif Methylation and a Role for RRM1 Ubiquitination (2012) (100)
- Cholinergic innervation and receptors in the cerebellum. (1997) (100)
- D 1 and D 2 dopamine receptor mRNA in rat brain ( striatum / substantia nigra / amygdala / septum / in situ hybridization ) (100)
- Polarized Expression of the Antidepressant-Sensitive Serotonin Transporter in Epinephrine-Synthesizing Chromaffin Cells of the Rat Adrenal Gland (1997) (99)
- M1 Muscarinic Acetylcholine Receptors Activate Extracellular Signal-Regulated Kinase in CA1 Pyramidal Neurons in Mouse Hippocampal Slices (2001) (99)
- Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP (2013) (97)
- Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (96)
- Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases (2018) (96)
- Association of GSK3B with Alzheimer disease and frontotemporal dementia. (2008) (96)
- Very early activation of m-calpain in peripheral nerve during Wallerian degeneration (2002) (95)
- Huntingtin-associated Protein 1 Interacts with Hepatocyte Growth Factor-regulated Tyrosine Kinase Substrate and Functions in Endosomal Trafficking* (2002) (95)
- Multiplex SILAC Analysis of a Cellular TDP-43 Proteinopathy Model Reveals Protein Inclusions Associated with SUMOylation and Diverse Polyubiquitin Chains* (2010) (94)
- High Blood Pressure and Cognitive Decline in Mild Cognitive Impairment (2013) (94)
- GABAB and group I metabotropic glutamate receptors in the striatopallidal complex in primates (2000) (91)
- Down‐Regulation of AMPA Receptor Subunit GluR2 in Amygdaloid Kindling (1995) (90)
- Localization of M2 muscarinic acetylcholine receptor protein in cholinergic and non-cholinergic terminals in rat hippocampus (2000) (90)
- Endogenous Presenilin-1 Targets to Endocytic Rather Than Biosynthetic Compartments (2000) (89)
- Phosphoproteomic analysis of human brain by calcium phosphate precipitation and mass spectrometry. (2008) (88)
- Distribution and Developmental Regulation of Metabotropic Glutamate Receptor 7a in Rat Brain (1998) (88)
- Rab5-dependent Trafficking of the m4 Muscarinic Acetylcholine Receptor to the Plasma Membrane, Early Endosomes, and Multivesicular Bodies* (2001) (87)
- An assessment by the Statin Cognitive Safety Task Force: 2014 update. (2014) (87)
- Transgenic Rescue of ataxia Mice with Neuronal-Specific Expression of Ubiquitin-Specific Protease 14 (2006) (86)
- Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. (2020) (86)
- Development of a rapid screening instrument for mild cognitive impairment and undiagnosed dementia. (2008) (84)
- Cortical inputs to m2‐immunoreactive striatal interneurons in rat and monkey (2000) (83)
- Regulation of the Subcellular Distribution of m4 Muscarinic Acetylcholine Receptors in Striatal Neurons In Vivo by the Cholinergic Environment: Evidence for Regulation of Cell Surface Receptors by Endogenous and Exogenous Stimulation (1999) (82)
- Proton Pump Inhibitors and Risk of Mild Cognitive Impairment and Dementia (2017) (81)
- Association of Early-Onset Alzheimer Disease With Elevated Low-density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of APOB. (2019) (81)
- Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice (2017) (81)
- Heptachlor alters expression and function of dopamine transporters. (1999) (81)
- Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia. (2018) (81)
- Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level (2021) (80)
- Tau-Mediated Disruption of the Spliceosome Triggers Cryptic RNA Splicing and Neurodegeneration in Alzheimer’s Disease (2019) (79)
- Muscarinic acetylcholine receptor subtype, m2: diverse functional implications of differential synaptic localization. (1997) (79)
- Daytime sleepiness and functional impairment in Alzheimer disease. (2007) (79)
- Ionotropic and metabotropic GABA and glutamate receptors in primate basal ganglia (2001) (77)
- Potassium channel Kv1.3 is highly expressed by microglia in human Alzheimer's disease. (2015) (77)
- Munc18 Interacting Proteins (2003) (77)
- Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer’s disease-related proteins (2018) (77)
- Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer’s disease (2017) (77)
- Regulation of muscarinic acetylcholine receptor function in acetylcholinesterase knockout mice (2003) (76)
- The association between late-life depression, mild cognitive impairment and dementia: is inflammation the missing link? (2012) (76)
- Aggregates of Small Nuclear Ribonucleic Acids (snRNAs) in Alzheimer's Disease (2014) (75)
- Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease. (2009) (75)
- Phosphoproteomic analysis reveals site-specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degeneration. (2010) (75)
- Distribution of high affinity choline transporter immunoreactivity in the primate central nervous system (2003) (74)
- Localization of the m2 muscarinic acetylcholine receptor protein and mRNA in cortical neurons of the normal and cholinergically deafferented rhesus monkey (1998) (74)
- Non-coding variability at the APOE locus contributes to the Alzheimer’s risk (2019) (74)
- Behavior Matters—Cognitive Predictors of Survival in Amyotrophic Lateral Sclerosis (2013) (73)
- The role of muscarinic acetylcholine receptor‐mediated activation of extracellular signal‐regulated kinase 1/2 in pilocarpine‐induced seizures (2002) (73)
- Analysis of a membrane‐enriched proteome from postmortem human brain tissue in Alzheimer's disease (2012) (73)
- CHOLINERGIC THERAPIES IN ALZHEIMER'S DISEASE (1999) (72)
- Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: implications for cholinergic-based therapies. (1995) (71)
- Molecular and functional identification of m1 muscarinic acetylcholine receptors in rat ventricular myocytes. (1996) (71)
- Development of transgenic rats producing human β-amyloid precursor protein as a model for Alzheimer's disease: Transgene and endogenous APP genes are regulated tissue-specifically (2008) (71)
- Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns (2017) (69)
- The production of monoclonal antibodies reactive with bovine choline acetyltransferase (1981) (69)
- Differential Phagocytic Properties of CD45low Microglia and CD45high Brain Mononuclear Phagocytes—Activation and Age-Related Effects (2018) (67)
- Association between polychlorinated biphenyls and Parkinson's disease neuropathology. (2012) (67)
- Immunological detection of glutamate receptor subtypes in human central nervous system (1992) (67)
- Quantitative phosphoproteomics of Alzheimer's disease reveals cross‐talk between kinases and small heat shock proteins (2015) (65)
- Multiscale causal networks identify VGF as a key regulator of Alzheimer’s disease (2020) (65)
- Dopamine axons in primate prefrontal cortex: specificity of distribution, synaptic targets, and development. (1998) (65)
- The Dopamine Transporter Carboxyl-terminal Tail (1996) (64)
- SPE-39 family proteins interact with the HOPS complex and function in lysosomal delivery. (2009) (64)
- Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice. (2003) (64)
- Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer’s disease: preclinical proof of concept (2018) (63)
- Choline acetyltransferase-like immunoreactivity in the forebrain of the red-eared pond turtle (Pseudemys scripta elegans) (1984) (63)
- On the distribution patterns of D1, D2, tyrosine hydroxylase and dopamine transporter immunoreactivities in the ventral striatum of the rat (1999) (63)
- Modulation of Renin‐Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease (2015) (63)
- Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain (2020) (61)
- Neuron enriched nuclear proteome isolated from human brain. (2013) (61)
- Subcellular Localization of Presenilins: Association with a Unique Membrane Pool in Cultured Cells (2000) (60)
- Infracortical interstitial cells concurrently expressing m2-muscarinic receptors, acetylcholinesterase and nicotinamide adenine dinucleotide phosphate-diaphorase in the human and monkey cerebral cortex (1998) (60)
- Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans (2012) (59)
- Interaction of Isoflurane with the Dopamine Transporter (2003) (59)
- Distribution of Group III mGluRs in Rat Basal Ganglia with Subtype‐Specific Antibodies (1999) (58)
- Rat dorsal root ganglia express m1-m4 muscarinic receptor proteins. (1999) (58)
- Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer’s disease (2017) (58)
- Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards. (2012) (57)
- Diverse pre- and post-synaptic expression of m1-m4 muscarinic receptor proteins in neurons and afferents in the rat neostriatum. (1995) (57)
- Effects of Hypertension and Hypercholesterolemia on Cognitive Functioning in Patients With Alzheimer Disease (2008) (57)
- 5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer's disease modulate Tau-induced neurotoxicity. (2016) (56)
- Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology (2020) (56)
- Muscarinic Activation of Mitogen‐Activated Protein Kinase in PC12 Cells (2000) (56)
- Development of muscarinic receptor subtypes in the forebrain of the mouse (1995) (55)
- Event-related potential changes in groups at increased risk for Alzheimer disease. (1999) (55)
- Rho Kinase II Phosphorylation of the Lipoprotein Receptor LR11/SORLA Alters Amyloid-β Production* (2010) (55)
- Cell-specific extracellular signal-regulated kinase activation by multiple G protein-coupled receptor families in hippocampus. (2003) (54)
- Asparaginyl endopeptidase cleaves TDP‐43 in brain (2012) (54)
- Recent Trends in Alzheimer Disease Mortality in the United States, 1999 to 2004 (2009) (53)
- The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory (2019) (52)
- Proteomics of protein post-translational modifications implicated in neurodegeneration (2014) (51)
- Changes in the detergent‐insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression (2016) (51)
- Rat Schwann cells express M1–M4 muscarinic receptor subtypes (2006) (50)
- Mint3/X11γ Is an ADP-Ribosylation Factor-dependent Adaptor that Regulates the Traffic of the Alzheimer's Precursor Protein from the Trans-Golgi Network (2008) (49)
- β-Hexachlorocyclohexane levels in serum and risk of Parkinson's disease. (2011) (48)
- Factors Affecting Survival of Patients with Neurodegenerative Disease (2010) (48)
- GGA1-mediated endocytic traffic of LR11/SorLA alters APP intracellular distribution and amyloid-β production (2012) (48)
- Brain proteome-wide association study implicates novel proteins in depression pathogenesis (2021) (48)
- Polymer-encapsulated PC-12 cells demonstrate high-affinity uptake of dopamine in vitro and 18F-Dopa uptake and metabolism after intracerebral implantation in nonhuman primates. (1997) (48)
- Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease (1999) (47)
- Selective enrichment of DJ‐1 protein in primate striatal neuronal processes: Implications for Parkinson's disease (2007) (47)
- Differential presynaptic and postsynaptic expression of m1–m4 muscarinic acetylcholine receptors at the perforant pathway/granule cell synapse (1998) (46)
- Immunochemical Studies of Bovine and Human Choline‐O‐Acetyltransferase Using Monoclonal Antibodie (1982) (46)
- Meta-analysis of the human brain transcriptome identifies heterogeneity across human AD coexpression modules robust to sample collection and methodological approach (2019) (46)
- Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer’s disease (2020) (45)
- Muscarinic receptor subtypes in the lateral geniculate nucleus: A light and electron microscopic analysis (1999) (45)
- Statins and Cognitive Decline in Older Adults with Normal Cognition or Mild Cognitive Impairment (2013) (44)
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (44)
- LSD1 protects against hippocampal and cortical neurodegeneration (2017) (44)
- Presenilin‐1 protein expression in familial and sporadic Alzheimer's disease (1997) (44)
- A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation (2017) (44)
- Presenilin 1 Independently Regulates β-Catenin Stability and Transcriptional Activity* (2001) (44)
- Proteomic analysis of postsynaptic density in Alzheimer's disease. (2013) (43)
- Cortical Proteins Associated With Cognitive Resilience in Community-Dwelling Older Persons. (2020) (43)
- Synthesis and evaluation of two 18F-labeled imidazo[1,2-a]pyridine analogues as potential agents for imaging β-amyloid in Alzheimer’s disease (2006) (43)
- Deficits in acetylcholine homeostasis, receptors and behaviors in choline transporter heterozygous mice (2007) (43)
- Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence (2021) (42)
- U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer’s disease due to autosomal dominant genetic mutations and trisomy 21 (2014) (42)
- Selective expression of m2 muscarinic receptor in the parvocellular channel of the primate visual cortex. (1996) (42)
- Cognitive Performance and Plasma Levels of Homocysteine, Vitamin B12, Folate and Lipids in Patients with Alzheimer Disease (2008) (42)
- Cross-species and intraspecies reactivities of monoclonal antibodies against choline acetyltransferase (1982) (42)
- Quantitative Analysis of the Brain Ubiquitylome in Alzheimer's Disease (2018) (42)
- Bacterial expression of human muscarinic receptor fusion proteins and generation of subtype‐specific antisera (1990) (41)
- A multiancestral genome-wide exome array study of Alzheimer disease, frontotemporal dementia, and progressive supranuclear palsy. (2015) (41)
- Synaptic and extrasynaptic GABA-A and GABA-B receptors in the globus pallidus: An electron microscopic immunogold analysis in monkeys (2005) (41)
- Alzheimer’s disease: A clinical perspective and future nonhuman primate research opportunities (2019) (41)
- Notch Signaling Inhibits PC12 Cell Neurite Outgrowth via RBP-J-Dependent and -Independent Mechanisms (2002) (40)
- Cultures of airway parasympathetic nerves express functional M2 muscarinic receptors. (1996) (40)
- Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors (2021) (40)
- Rarity of the Alzheimer disease-protective APP A673T variant in the United States. (2015) (39)
- Muscarinic receptor M2 in cat visual cortex: Laminar distribution, relationship to γ‐aminobutyric acidergic neurons, and effect of cingulate lesions (2001) (39)
- Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau (2020) (38)
- Integrating Next-Generation Genomic Sequencing and Mass Spectrometry To Estimate Allele-Specific Protein Abundance in Human Brain. (2017) (38)
- Altered hippocampal muscarinic receptors in acetylcholinesterase‐deficient mice (2003) (38)
- RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease (2018) (38)
- Fas-associated factor 1 and Parkinson's disease (2008) (37)
- Postnatal development of tyrosine hydroxylase- and dopamine transporter-immunoreactive axons in monkey rostral entorhinal cortex. (1998) (36)
- Immunohistochemistry of choline acetyltransferase in the guinea pig brain (1988) (36)
- The dysarthria—clumsy hand syndrome: A distinct clinical entity related to pontine infarction (1990) (36)
- Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer’s Disease (2017) (36)
- Effects of APOE Genotype on Brain Proteomic Network and Cell Type Changes in Alzheimer's Disease (2018) (36)
- Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics (2019) (35)
- Differential subcellular and subsynaptic distribution of GABAA and GABAB receptors in the monkey subthalamic nucleus (2004) (35)
- Novel Interaction between the M4 Muscarinic Acetylcholine Receptor and Elongation Factor 1A2* (2002) (35)
- Effects of Candesartan vs Lisinopril on Neurocognitive Function in Older Adults With Executive Mild Cognitive Impairment (2020) (35)
- Disease-Modifying Effects of M1 Muscarinic Acetylcholine Receptor Activation in an Alzheimer's Disease Mouse Model. (2017) (35)
- An exploration of subgroups of mild cognitive impairment based on cognitive, neuropsychiatric and functional features: analysis of data from the National Alzheimer's Coordinating Center. (2011) (34)
- Brain microRNAs associated with late-life depressive symptoms are also associated with cognitive trajectory and dementia (2019) (34)
- Muscarinic acetylcholine receptor immunoreactivity after hippocampal commissural/associational pathway lesions: Evidence for multiple presynaptic receptor subtypes (1997) (34)
- Paraoxonase-1 polymorphisms in Alzheimer's disease, Parkinson's disease, and AD-PD spectrum diseases (2012) (34)
- CSF beta-amyloid 1–42 – what are we measuring in Alzheimer's disease? (2014) (33)
- Identification of Conserved Proteomic Networks in Neurodegenerative Dementia (2019) (33)
- m2 Muscarinic receptor immunolocalization in cholinergic cells of the monkey basal forebrain and striatum (1999) (33)
- Radioligand binding and immunoautoradiographic evidence for a lack of toxicity to dopaminergic nerve terminals in human cocaine overdose victims (1997) (33)
- Elongation Factor 1A Family Regulates the Recycling of the M4 Muscarinic Acetylcholine Receptor (2006) (32)
- PARK10 Candidate RNF11 Is Expressed by Vulnerable Neurons and Localizes to Lewy Bodies in Parkinson Disease Brain (2007) (32)
- Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease (2013) (32)
- Aggregation Properties of the Small Nuclear Ribonucleoprotein U1-70K in Alzheimer Disease* (2014) (32)
- Distribution of muscarinic cholinergic receptor proteins m1 to m4 in area 17 of normal and monocularly deprived rhesus monkeys (1997) (31)
- Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease (2020) (31)
- Functional downregulation of GluR2 in piriform cortex of kindled animals (2000) (31)
- Genetic control of the human brain proteome (2019) (31)
- Merger of laser capture microdissection and mass spectrometry: a window into the amyloid plaque proteome. (2006) (31)
- LIM kinase 1 accumulates in presynaptic terminals during synapse maturation (2000) (30)
- Racial Disparity in Cognitive and Functional Disability in Hypertension and All-Cause Mortality. (2016) (30)
- Acute mitochondrial and chronic toxicological effects of 1-methyl-4-phenylpyridinium in human neuroblastoma cells. (2002) (29)
- Subpopulations of rat dorsal root ganglion neurons express active vesicular acetylcholine transporter (2004) (29)
- Diffuse Plaques in the Striatum in Alzheimer Disease (AD): Relationship to the Striatal Mosaic and Selected Neuropeptide Markers (1997) (29)
- Increased plasma TACE activity in subjects with mild cognitive impairment and patients with Alzheimer's disease. (2014) (28)
- A feasibility trial of gamma sensory flicker for patients with prodromal Alzheimer's disease (2021) (28)
- RNF11 modulates microglia activation through NF-κB signalling cascade (2012) (27)
- CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease (2016) (27)
- Immunolocalization of muscarinic acetylcholine subtype 2 receptors in rat cochlear nucleus (1996) (27)
- Women can bear a bigger burden: ante- and post-mortem evidence for reserve in the face of tau (2020) (26)
- Transcriptional regulation of homeostatic and disease‐associated‐microglial genes by IRF1, LXRβ, and CEBPα (2019) (26)
- White matter hyperintensities and changes in white matter integrity in patients with Alzheimer’s disease (2011) (26)
- Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (26)
- Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease (2021) (25)
- Inflammation and cognitive functioning in African Americans and Caucasians (2015) (25)
- Seizures following myelography with iopamidol (1988) (25)
- Abnormal gephyrin immunoreactivity associated with Alzheimer disease pathologic changes. (2013) (25)
- Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial. (2021) (24)
- Mint3/X11gamma is an ADP-ribosylation factor-dependent adaptor that regulates the traffic of the Alzheimer's Precursor protein from the trans-Golgi network. (2008) (24)
- Sequestration of Muscarinic Cholinergic Receptors in Permeabilized Neuroblastoma Cells (1994) (24)
- Light-microscopic distribution and parasagittal organisation of muscarinic receptors in rabbit cerebellar cortex (1995) (24)
- White Matter Integrity and Episodic Memory Performance in Mild Cognitive Impairment: A Diffusion Tensor Imaging Study (2009) (24)
- Integrated Approaches for Analyzing U1-70K Cleavage in Alzheimer’s Disease (2014) (24)
- The State of Systems Genetics in 2017. (2017) (24)
- Association Between Angiotensin Receptor Blockers and Longitudinal Decline in Tau in Mild Cognitive Impairment. (2015) (24)
- Coordinate Expression of the Vesicular Acetylcholine Transporter and Choline Acetyltransferase Following Septohippocampal Pathway Lesions (1998) (23)
- TREM 2 is associated with increased risk for Alzheimer ' s disease in African Americans (23)
- NF-κB activity is inversely correlated to RNF11 expression in Parkinson's disease (2013) (23)
- Differential effects of allosteric M(1) muscarinic acetylcholine receptor agonists on receptor activation, arrestin 3 recruitment, and receptor downregulation. (2010) (23)
- Cloning and Localization of Exon 5‐Containing Isoforms of the NMDAR1 Subunit in Human and Rat Brains (1997) (22)
- Viscoelastic Properties of Human Autopsy Brain Tissues as Biomarkers for Alzheimer's Diseases (2019) (22)
- Extracellular signal‐regulated kinase regulates microglial immune responses in Alzheimer’s disease (2021) (22)
- 18F-florbetapir Positron Emission Tomography–determined Cerebral &bgr;-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery (2018) (21)
- Rationale and Design of the Emory Healthy Aging and Emory Healthy Brain Studies (2019) (21)
- The Relationship Between Cognitive Functioning and the JNC-8 Guidelines for Hypertension in Older Adults (2017) (21)
- Neurobiologic Rationale for Treatment of Apathy in Alzheimer’s Disease With Methylphenidate (2020) (20)
- Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer’s Disease via Fusion of Clinical, Imaging and Omic Features (2017) (20)
- Proteomic Analysis of Hippocampal Dentate Granule Cells in Frontotemporal Lobar Degeneration: Application of Laser Capture Technology (2011) (20)
- Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer’s disease (2019) (20)
- KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease (2021) (19)
- Evidence of shared risk for Alzheimer’s disease and Parkinson’s disease using family history (2007) (19)
- A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data (2019) (19)
- Immunohistochemical Localization of Proteins in the Nervous System (2003) (19)
- Comparative distribution of protein components of the A20 ubiquitin-editing complex in normal human brain (2012) (19)
- VisMET: a passive, efficient, and sensitive assessment of visuospatial memory in healthy aging, mild cognitive impairment, and Alzheimer's disease (2019) (18)
- ADP-RIBOSYLATION FACTOR-DEPENDENT COAT PROTEINS THAT REGULATE THE TRAFFIC OF -ALZHEIMER'S PRECURSOR PROTEIN* (2003) (17)
- Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease (2021) (17)
- Progress with Treatments for Alzheimer's Disease. (2021) (17)
- Shared mechanisms across the major psychiatric and neurodegenerative diseases (2022) (16)
- Mint 3 / X 11 Is an ADP-Ribosylation Factor-dependent Adaptor that Regulates the Traffic of the Alzheimer ’ s Precursor Protein from the Trans-Golgi Network (2007) (16)
- Characterization of Detergent Insoluble Proteome in Chronic Traumatic Encephalopathy (2018) (16)
- Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways (2016) (16)
- Neuronal RING finger protein 11 (RNF11) regulates canonical NF-κB signaling (2012) (16)
- Large‐scale deep multi‐layer analysis of Alzheimer’s disease brain reveals strong proteomic disease‐related changes not observed at the RNA level (2021) (16)
- Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status (2021) (16)
- Evidence for the presence of muscarinic M2 and M4 receptors in guinea-pig gallbladder smooth muscle. (1998) (15)
- Purpose in life is a robust protective factor of reported cognitive decline among late middle-aged adults: The Emory Healthy Aging Study. (2019) (15)
- Striatal dopamine nerve terminal markers but not nigral cellularity are reduced in spinocerebellar ataxia type 1 (1997) (15)
- Unique molecular characteristics and microglial origin of Kv1.3 channel–positive brain myeloid cells in Alzheimer’s disease (2021) (15)
- Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (15)
- Network Analysis of a Membrane-Enriched Brain Proteome across Stages of Alzheimer’s Disease (2019) (15)
- Destruction of Midbrain Dopaminergic Neurons by Using Immunotoxin to Dopamine Transporter (2003) (15)
- Potassium Channel Kv 1 . 3 Is Highly Expressed by Microglia in Human Alzheimer ' s Disease (2015) (14)
- Aberrant septin 11 is associated with sporadic frontotemporal lobar degeneration (2011) (14)
- Neurocognitive correlates of nocturnal oxygen desaturation in a memory clinic population (2012) (14)
- Association of GSK 3 B With Alzheimer Disease and Frontotemporal Dementia (2008) (14)
- Hippocampal place cell dysfunction and the effects of muscarinic M1 receptor agonism in a rat model of Alzheimer's disease (2018) (13)
- RING finger protein 11 (RNF11) modulates susceptibility to 6-OHDA-induced nigral degeneration and behavioral deficits through NF-κB signaling in dopaminergic cells (2013) (13)
- The regulation of presenilin‐1 by nerve growth factor (2001) (13)
- Neuronal LR11 Expression Does Not Differentiate between Clinically-Defined Alzheimer's Disease and Control Brains (2012) (13)
- Multiscale causal network models of Alzheimer’s disease identify VGF as a key regulator of disease (2018) (12)
- The impact of vascular comorbidities on qualitative error analysis of executive impairment in Alzheimer’s disease (2009) (12)
- Synthesis and In Vitro Evaluation of Imidazo[1,2-b]pyridazines as Ligands for β-Amyloid Plaques. (2010) (12)
- Geographical Differences in the Occurrence of Alzheimer's Disease Mortality: United States Versus Puerto Rico (2008) (12)
- A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease (2016) (12)
- Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study (2021) (12)
- Is ApoE &egr;4 Associated with Cognitive Functioning in African Americans Diagnosed with Alzheimer Disease? An Exploratory Study (2009) (11)
- A 'Framingham-like' Algorithm for Predicting 4-Year Risk of Progression to Amnestic Mild Cognitive Impairment or Alzheimer's Disease Using Multidomain Information. (2018) (11)
- Deep Convolutional Neural Networks and Transfer Learning for Measuring Cognitive Impairment Using Eye-Tracking in a Distributed Tablet-Based Environment (2020) (11)
- REDLetr: Workflow and tools to support the migration of legacy clinical data capture systems to REDCap (2016) (11)
- The impact of PICALM genetic variations on reserve capacity of posterior cingulate in AD continuum (2016) (10)
- Feedforward prediction error signals during episodic memory retrieval (2020) (10)
- Targeted Quantification of Detergent-Insoluble RNA-Binding Proteins in Human Brain Reveals Stage and Disease Specific Co-aggregation in Alzheimer’s Disease (2021) (10)
- Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease (2022) (9)
- A PROOF OF CONCEPT PHASE II STUDY REPURPOSING ATOMOXETINE FOR NEUROPROTECTION IN MILD COGNITIVE IMPAIRMENT: EVIDENCE FOR TARGET ENGAGEMENT, REGULATION OF CSF BIOMARKERS, AND DISEASE-MODIFYING POTENTIAL (2019) (9)
- FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (2020) (9)
- Effects of Selective M1 Muscarinic Receptor Activation on Hippocampal Spatial Representations and Neuronal Oscillations. (2016) (9)
- Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer’s disease (2021) (9)
- Atlas of RNA editing events affecting protein expression in aged and Alzheimer’s disease human brain tissue (2021) (9)
- Reply: LATE to the PART-y. (2019) (8)
- TBK1 interacts with tau and enhances neurodegeneration in tauopathy (2020) (8)
- Multi-platform proteomic analysis of Alzheimer’s disease cerebrospinal fluid and plasma reveals network biomarkers associated with proteostasis and the matrisome (2022) (8)
- Microglial ERK activation is a critical regulator of pro-inflammatory immune responses in Alzheimer’s disease (2019) (8)
- Automated analysis of facial emotions in subjects with cognitive impairment (2022) (8)
- Generation of transporter-specific antibodies. (1998) (8)
- Cell type-specific biotin labeling in vivo resolves regional neuronal and astrocyte proteomic differences in mouse brain (2022) (8)
- A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease (2020) (8)
- Correlation between Alzheimer’s disease and type 2 diabetes using non-negative matrix factorization (2021) (7)
- MEASURING APATHY IN ALZHEIMER'S DISEASE IN THE APATHY IN DEMENTIA METHYLPHENIDATE TRIAL 2 (ADMET 2): A COMPARISON OF INSTRUMENTS (2017) (7)
- Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease (2021) (7)
- Maximizing Safety in the Conduct of Alzheimer's Disease Fluid Biomarker Research in the Era of COVID-19. (2020) (7)
- Mass Spectrometry-Based Quantification of Tau in Human Cerebrospinal Fluid Using a Complementary Tryptic Peptide Standard. (2019) (7)
- CSF and Neuropsychological Correlates of Visual Hallucination in Dementia with Lewy Bodies (2014) (7)
- A predictive model using the mesoscopic architecture of the living brain to detect Alzheimer’s disease (2022) (7)
- Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease (2022) (6)
- Predictive Model for Early Detection of Mild Cognitive Impairment and Alzheimer’s Disease (2013) (6)
- Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume (2022) (6)
- Genetic Evidence Supporting a Causal Role of Depression in Alzheimer’s Disease (2021) (6)
- Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference (2018) (6)
- [20] Anti-fusion protein antibodies specific for receptor subtypes (1995) (6)
- Cloning of M‐calpain 80 kD subunit from the axonal degeneration‐resistant WLDs mouse mutant (1998) (6)
- Molecules of the Brain (2000) (6)
- Predicting Alzheimer’s disease progression using multi-modal deep learning approach (2019) (6)
- The landscape of metabolic brain alterations in Alzheimer’s disease (2021) (5)
- U1 small nuclear ribonucleoproteins (snRNPs) aggregate in Alzheimer’s disease due to autosomal dominant genetic mutations and trisomy 21 (2014) (5)
- Neuropathologic Correlates of Human Cortical Proteins in Alzheimer Disease and Related Dementias (2021) (5)
- Integrating human brain proteomes with genome-wide association data implicates novel proteins in post-traumatic stress disorder (2022) (5)
- Alzheimer disease risk factors. (2014) (5)
- Frequency of the TREM2 R47H Variant in Various Neurodegenerative Disorders (2019) (5)
- Association of plasma and CSF cytochrome P450, soluble epoxide hydrolase, and ethanolamide metabolism with Alzheimer’s disease (2021) (5)
- The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory (2019) (5)
- An IL1RL1 genetic variant lowers soluble ST2 levels and the risk effects of APOE-ε4 in female patients with Alzheimer’s disease (2022) (5)
- Signatures of glial activity can be detected in the CSF proteome (2022) (5)
- Alzheimer’s disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions (2021) (5)
- Dissection of the polygenic architecture of neuronal Aβ production using a large sample of individual iPSC lines derived from Alzheimer’s disease patients (2022) (4)
- Mental stress-induced myocardial ischemia and cognitive impairment in coronary atherosclerosis. (2020) (4)
- Manifestations of Alzheimer’s disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90 (2022) (4)
- Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts (2016) (4)
- CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels (2022) (4)
- Assessment of cholesterol homeostasis in the living human brain (2022) (4)
- A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation (2017) (4)
- Hypertension and Alzheimer disease: is there a link? (2012) (3)
- Safety and biomarker effects of candesartan in non-hypertensive adults with prodromal Alzheimer’s disease (2022) (3)
- Phenylephrine and norepinephrine increase dopamine transporter ligand binding in striatum. (2003) (3)
- Brain microRNAs associated with late-life depressive symptoms are also associated with cognitive trajectory and dementia (2020) (3)
- 142nd Annual Meeting of the American Neurological Association (1978) (3)
- Chronically mad as a hatter: Anticholinergics and Alzheimer's disease pathology (2003) (3)
- Priorities for research on neuromodulatory subcortical systems in Alzheimer's disease: Position paper from the NSS PIA of ISTAART. (2023) (3)
- The Feasibility of Measuring Gait in an Outpatient Cognitive Neurology Clinical Setting. (2019) (3)
- Informed Consent in Two Alzheimer’s Disease Research Centers: Insights From Research Coordinators (2020) (3)
- Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology (2020) (3)
- Functional Screening of Drug Target Genes (2004) (3)
- Cerebral atherosclerosis contributes to Alzheimer’s dementia independently of its hallmark amyloid and tau pathologies (2019) (3)
- Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease (2020) (3)
- Synthesis and evaluation of two 18F-labeled imidazo[1,2-a]pyridine analogues as potential agents for imaging beta-amyloid in Alzheimer's disease. (2006) (3)
- Functional screening of drug target genes: m1 muscarinic acetylcholine receptor phenotypes in degenerative dementias. (2004) (2)
- A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment. (2021) (2)
- Proteomic analysis of the poly‐ubiquitin profiles in Alzheimer's Disease (2019) (2)
- Common pattern of deficit in multinational MCI cohort identified by objective computerized cognitive assessment (2005) (2)
- Fibrillation and molecular characteristics are coherent with clinical and pathological features of 4-repeat tauopathy caused by MAPT variant G273R (2020) (2)
- Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer’s disease-related proteins (2018) (2)
- A Genetic Study of Cerebral Atherosclerosis Reveals Novel Associations with NTNG1 and CNOT3 (2021) (2)
- Immunization for Alzheimer's disease: A shot in the arm or a whiff? (2000) (2)
- P1-130 The “Mini-cog” as a screen for dementia: validation in an African American population (2004) (2)
- Brain microRNAs are associated with variation in cognitive trajectory in advanced age (2019) (2)
- Cerebral Aβ deposition in an Aβ-precursor protein-transgenic rhesus monkey (2022) (2)
- CO‐registration of proton magnetic resonance spectroscopy (1H‐MRS) and diffusion imaging (DMRI) in healthy aging: A prospective study of cerebral neurochemistry and microstructure (2020) (2)
- Neuronal RING finger protein 11 (RNF11) regulates canonical NF-κB signaling (2012) (2)
- Mint3/X11 gamma is an ADP-ribosylation factor-dependent adaptor that regulates the traffic of the Alzheimer's precursor protein from the trans-Golgi network (2)
- DOPAMINE RECEPTORS IN THE BASAL GANGLIA OF THE RAT : LIGHT AND ELECTRON MICROSCOPY (2003) (2)
- Renin-Angiotensin-System Modulation may slow the Conversion from Mild Cognitive Impairment to Alzheimer’s Disease (2016) (2)
- Association between Symptoms of Psychological Distress and Cognitive Functioning among Adults with Coronary Artery Disease. (2020) (2)
- Immunochemical analysis of dopamine transporters in Parkinson's disease. (2001) (2)
- P1-075 Behavioral tasks and eye-tracking technology for early diagnosis of Alzheimer's disease in patients with mild cognitive impairment (MCI) (2004) (1)
- Machine Learning Selection of Most Predictive Brain Proteins Suggests Role of Sugar Metabolism in Alzheimer’s Disease (2023) (1)
- Integrating human brain proteomes and genome‐wide association results implicates new genes in Alzheimer’s disease (2020) (1)
- Racial‐ethnic differences in baseline and longitudinal change in neuropsychological test scores in the NACC Uniform Data Set 3.0 (2021) (1)
- Vesicular monoamine transporter immunoreactivity is reduced in Parkinsons diseased striatum (1996) (1)
- Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease (2013) (1)
- Erratum: Complex relationship between Parkin mutations and Parkinson disease (American Journal of Medical Genetics-Neuropsychocetric (2002) 114-(584-591)) (2002) (1)
- Predicting the onset of Alzheimer's disease with a behavioral task (2011) (1)
- Author Correction: Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (2021) (1)
- Alzheimer's disease genetic burden is associated with mid‐life depression among persons with normal cognition (2022) (1)
- Targeting the Moesin‐CD44 pathway for therapeutic intervention in Alzheimer’s disease (2020) (1)
- Depression contributes to Alzheimer’s disease through shared genetic risk (2021) (1)
- Higher arterial stiffness but not blood pressure is associated with brain amyloidosis and preclinical AD in healthy adults: Results from the Emory Healthy Brain Study (2020) (1)
- Cell type-specific biotin labeling in vivo resolves regional neuronal proteomic differences in mouse brain (2021) (1)
- Production of Antisera Using Fusion Proteins (1997) (1)
- FEASIBILITY OF AMBULATORY OVERNIGHT OXIMETRY IN CONSECUTIVE PATIENTS IN A DEMENTIA CLINIC (2005) (1)
- LDL cholesterol is associated with higher AD neuropathology burden independent of APOE (2022) (1)
- Erratum: Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. (Brain (2019) 142, (1503–1527) DOI: 10.1093/brain/awz099) (2019) (1)
- The 5th International Conference on Molecular Neurodegeneration: Overlapping Pathologies and Common Mechanisms (2019) (1)
- Quantitative multiplexed proteomics of mouse microglia by flow-cytometric sorting reveals a core set of highly-abundant microglial proteins (2019) (1)
- TREM2 is associated with increased risk for Alzheimer’s disease in African Americans (2015) (1)
- Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age (2019) (1)
- Targeted mass spectrometry to quantify brain-derived cerebrospinal fluid biomarkers in Alzheimer’s disease (2020) (1)
- Behavioral performance as a predictor of cognitive decline: Detecting the transition from healthy aging to mild cognitive impairment (2012) (1)
- the Risk of Myocardial Infarction A Common Variant on Chromosome 9 p 21 Affects (2008) (1)
- Cognitive Empowerment Program for Individuals with Mild Cognitive Impairment: Description and Preliminary Satisfaction Ratings (2020) (1)
- Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer's disease (2013) (1)
- Erratum: Infracortical interstitial cells concurrently expressing m2- muscarinic receptors, acetylcholinesterase and nicotinamide adenine dinucleotide phosphate-diaphorase in the human and monkey cerebral cortex (Neuroscience (1998) 84 (755-769)) (1998) (1)
- Examination of the reliability and feasibility of two smartphone applications to assess executive functioning in racially diverse older adults (2021) (1)
- Certain antihypertensives may slow the conversion from mild cognitive impairment to Alzheimer’s disease (2015) (1)
- Elevated serum DDE and risk for Alzheimer disease--reply. (2014) (1)
- Polymer-Encapsulated PC-12 Cells Demonstrate High-Affinity Uptake of Dopamine in Vitro and 18F-DOPA Uptake and Metabolism after Intracerebral Implantation in Nonhuman Primates (1997) (1)
- Global quantitative analysis of the human brain proteome and phosphoproteome in Alzheimer’s disease (2020) (1)
- AMultiancestral Genome-Wide Exome Array Study of Alzheimer Disease , Frontotemporal Dementia , and Progressive Supranuclear Palsy (2015) (1)
- THE ACUTE PHASE PROTEIN ALPHA-2-MACROGLOBULIN PREDICTS RISK OF INCIDENT ALZHEIMER'S DISEASE AND MODULATES TAU PATHOLOGY THROUGH THE RCAN1-CALCINEURIN PATHWAY (2016) (0)
- Evidence for dose-dependent neurotoxicity of amyloid-β oligomers/Aβ-derived diffusible ligands generated from physiological processing of transgenic human APP in situ in mouse brain (2010) (0)
- Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) (0)
- Cholinergic and neurotrophic markers within the nucleus basalis in elderly individuals with mild cognitive impairment and early Alzheimer's disease (2000) (0)
- P1-170: Non-verbal memory performance is associated with conversion to dementia within one year: A prospective study of mild cognitive impairment using computerized cognitive assessment (2008) (0)
- Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia (2018) (0)
- First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease: the Dominantly Inherited Alzheimer’s Network Study (2022) (0)
- Analysis of the functional role of endosomal presenilin-1 (2000) (0)
- FUNCTIONAL GENETIC DISSECTION OF AN ALZHEIMER’S DISEASE SUSCEPTIBILITY NETWORK (2018) (0)
- BRAIN MICRORNAS ASSOCIATED WITH LATE-LIFE DEPRESSION ARE ALSO LINKED TO COGNITIVE TRAJECTORY AND DEMENTIA (2019) (0)
- Ftld-tdp to Tau Ratio Is a Biomarker for 181 Reduced Csf P-tau (0)
- S3-04-02: Muscarinic acetylcholine receptor subtype regulation of amyloid precursor protein processing (2008) (0)
- Correction to: Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer’s disease (2021) (0)
- Additional file 1: Table S1. of CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease (2016) (0)
- REGULATION OF PRO-INFLAMMATORY AND DISEASE-ASSOCIATED MICROGLIAL ACTIVATION BY BIN1 (2019) (0)
- Molecules of senescent glial cells differentiate Alzheimer’s disease from ageing (2023) (0)
- A matrisomal proteomics network modulates tau and amyloid‐beta toxicity in fly AD models. (2022) (0)
- Tool and chemical probe development for emerging targets in Alzheimer’s disease: The Emory‐Sage‐SGC TREAT‐AD Center (2021) (0)
- Protein co-expression network analysis in Alzheimer’s disease (2015) (0)
- Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease (2018) (0)
- Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (2020) (0)
- Proteome-wide discovery of cortical proteins that may provide motor resilience to offset the negative effects of pathologies in older adults. (2022) (0)
- FUNCTIONAL DISSECTION OF AN ALZHEIMER’S DISEASE SUSCEPTIBILITY GENE NETWORK (2019) (0)
- SORTOUT‐AB: A Study of Race to Understand Alzheimer Biomarkers (2022) (0)
- Muscarinic activation of MAPK in PC12 cells (1999) (0)
- P2-246 APOE4 genotype and sleep apnea in Alzheimer's disease: initial studies (2004) (0)
- Stimulation of muscarinic receptors in vivo induces dramatic modifications of the subcellular distribution of the m2 muscarinic receptor in striatal interneurons (1998) (0)
- Integration of proteomics and metabolomics - insights into inflammation, metabolic dysregulation, and vascular aspects in AD (2022) (0)
- Author Correction: Multimodal hippocampal subfield grading for Alzheimer’s disease classification (2020) (0)
- Friday, March 16, 2007. pp. 97–134 (2007) (0)
- Spread of pathological tau proteins through communicating neurons in human Alzheimer’s disease (2020) (0)
- P1-023 Functional abilities in patients with mild cognitive impairment versus Alzheimer's disease and normal controls (2004) (0)
- Response to Buslovich and Colleagues (2014) (0)
- Neurobiological Pathways Linking Acute Mental Stress to Impairments in Executive Function in Individuals with Coronary Artery Disease (2021) (0)
- Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer’s disease (2022) (0)
- DO EPIGENETIC AND TRANSCRIPTOMIC PATTERNS EXPLAIN THE ASSOCIATION BETWEEN LATE-LIFE DEPRESSION AND INCREASED RISK FOR DEMENTIA? (2019) (0)
- p3-Alc peptides produced by covariant processing of Alcadein and APP implicate γ-secretase dysfunction in sporadic Alzheimer's disease (2009) (0)
- Human Brain Proteome-Wide Association Study of Depression Identified 24 Proteins as Tractable Targets for Further Mechanistic Studies (2020) (0)
- SEX-SPECIFIC PROTEIN DIFFERENCES LINKED TO ALZHEIMER’S DISEASE RISK UNCOVERED BY A COEXPRESSION-REGRESSION FRAMEWORK (2019) (0)
- Novel proteomic molecular signatures of brain endothelial cells and microglia in the aging mouse brain (2020) (0)
- Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) (0)
- Publisher Correction: Shared proteomic effects of cerebral atherosclerosis and Alzheimer’s disease on the human brain (2020) (0)
- Early-onset Alzheimer's disease likely has autosomal recessive causes (2011) (0)
- Molecular and behavioral phenotypes caused by selective disruption of M4 muscarinic acetylcholine receptors in D1 dopamine receptor‐expressing cells (2008) (0)
- The Georgia Memory Net: Implementation of a statewide program to diagnose and treat Alzheimer's disease and related dementias (2022) (0)
- P3-057 The impact of vascular risk on concept formation in Alzheimer’s disease (2006) (0)
- Tau phosphosignatures discriminate Alzheimer Disease from other tauopathies (2015) (0)
- P2-181 A prospective study of cognitive performance in amnestic MCI using comprehensive computerized assessment (2006) (0)
- RNA-BINDING PROTEINS WITH MIXED CHARGE DOMAINS SELF-ASSEMBLE AND AGGREGATE IN ALZHEIMER'S DISEASE (2018) (0)
- DEVELOPING AN ELECTRONIC CONSENT FOR ADRC HIGH COMPLIANCE, CONTINUOUS LONG-TERM HOME MONITORING OF SLEEP ACTIVITY IN DIVERSE POPULATIONS DIFFERENTIATES LOWER COGNITIVE FUNCTIONING OLDER ADULTS (2019) (0)
- O4-09-03 IMMUNOSUPPRESSION EXACERBATES ALZHEIMER’S DISEASE PATHOLOGY IN APP/PS1 TRANSGENIC MICE (2019) (0)
- P3-295 Quantification of LR11 expression in mild cognitive impairment, a human model for early Alzheimer's disease (2004) (0)
- Proteomics of protein post-translational modifications implicated in neurodegeneration (2014) (0)
- The location of PSEN1 pathogenic variants in transmembrane vs. cytoplasmic domains may alter neurodegenerative and cognitive trajectories: Findings from the DIAN study (2021) (0)
- Diabetes-linked SORCS1, a gamma-secretase substrate and regulator of Alzheimer APP metabolism, forms complexes with multiple Alzheimer-linked proteins (APP, PS1, BACE, VPS35, and SORLA) (2010) (0)
- Deep proteomic network analysis of Alzheimer’s disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease (2018) (0)
- MOLECULAR AND OMICS-BASED ANALYSES ATRANSCRIPTOMIC LANDSCAPE OF MICROGLIAL ACTIVATION IN ALZHEIMER’S DISEASE (2018) (0)
- Unbiased Classification of the Human Brain Proteome Resolves Distinct Clinical and Pathophysiological Subtypes of Cognitive Impairment (2022) (0)
- PROTEIN CO-EXPRESSION NETWORK ANALYSIS IN ASYMPTOMATIC AND SYMPTOMATIC ALZHEIMER'S DISEASE (2017) (0)
- A blood-based signature of cerebrospinal fluid Aβ1–42 status (2019) (0)
- AD‐causing variants that affect PSEN1 transmembrane domains are associated with faster neurodegeneration and cognitive decline compared to those affecting cytoplasmic domains. (2022) (0)
- genetic Alzheimer’s disease Integrating human brain proteomes and genome-wide association results implicates new genes in Alzheimer’s disease (2020) (0)
- A TRANSCRIPTOMIC LANDSCAPE OF MICROGLIAL ACTIVATION IN ALZHEIMER’S DISEASE (2018) (0)
- P3-303 Examining the role of the APOE receptor LR11 in the etiopathology of Alzheimer's disease (2004) (0)
- Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation (2020) (0)
- CSF protein panels reflecting multiple pathophysiological mechanisms for early and specific diagnosis of Alzheimer’s disease (2021) (0)
- Author Correction: FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease (2022) (0)
- O2-02-05 RNA-BINDING PROTEINS WITH MIXED CHARGEDOMAINS SELF-ASSEMBLE AND AGGREGATE IN ALZHEIMER’S DISEASE (2018) (0)
- Davos Alzheimer’s Collaborative: Building a globally representative cohort through a technologically‐enabled approach (2022) (0)
- CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease (2016) (0)
- Phenotypic Differences In Cholinergic Markers Within The Nucleus Basalis In Individuals With Mild Cognitive Impairment (2002) (0)
- Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics (2019) (0)
- Apathy in Dementia Methylphenidate Trial 2 (ADMET2): Results of a phase III, placebo‐controlled, double‐blind, 6‐month, multi‐center, randomized clinical trial (2021) (0)
- Correction to: Exploring the potential of the platelet membrane proteome as a source of peripheral biomarkers for Alzheimer’s disease (2021) (0)
- Mutual inhibition between the notch and WNT signalling pathways in mammalian cell lines (2002) (0)
- Brain phosphoproteome network analysis discriminates Alzheimer's disease from other tauopathies (2015) (0)
- Heterogeneity of response to methylphenidate in apathetic patients in the ADMET 2 Trial (2022) (0)
- A longitudinal study of gait on fall risk and disease progression in patients with mild cognitive impairment and Alzheimer's disease (2020) (0)
- Erratum (1979) (0)
- 1 OXIDATIVE MODIFICATIONS AND AGGREGATION OF Cu / Zn SUPEROXIDE DISMUTASE ASSOCIATED WITH ALZHEIMER ' S AND PARKINSON ' S DISEASES * (2004) (0)
- PROTEOMIC NETWORK ANALYSIS TO FIND COMMON MECHANISMS UNDERLYING ALZHEIMER'S DISEASE AND PD (2016) (0)
- Fine particulate air pollution and neuropathology markers of Alzheimer’s disease in donors with and without APOE ε4 alleles – results from an autopsy cohort (2023) (0)
- TAU CYTOPATHOLOGY IN A PATIENT WITH FAMILIAL EARLY ONSET DEMENTIA (1998) (0)
- P4-143 Identification of the apoe receptor sorLA/LR11 as a novel component of hallmark Alzheimer’s disease-related lesions in down syndrome (2006) (0)
- AND PROTEOMICS INTEGRATIVE PROTEOMICS LINKS CEREBROSPINAL FLUID BIOMARKERS TO PATHOLOGICAL NETWORKS IN THE ALZHEIMER’S DISEASE BRAIN HIPPOCAMPAL ATROPHY (2019) (0)
- Podium Presentations: Wednesday, July 25, 2018 P1394 F4-07-04 THE CONSEQUENCES OF TAU IN THE LOCUS COERULEUS ON ALZHEIMER’S DISEASE (2018) (0)
- DISCOVERY OF NOVEL PROTEOMIC TARGETS FOR TREATMENT OF ALZHEIMER'S DISEASE (2016) (0)
- RNA-binding proteins with mixed charge domains self-assemble and aggregate in Alzheimer’s Disease (2018) (0)
- P-073: Elevated Serum Levels of p,pʼ-DDE are Associated with Increased Risk for Alzheimerʼs Disease (2012) (0)
- Increased Expression Of Kv1.3 Channels By Microglia In Alzheimer’s Disease (P1.240) (2014) (0)
- INTEGRATED PROTEOMICS AND PHOSPHOPROTEOMICS REVEAL NETWORKS LINKED TO ALZHEIMER’S DISEASE RISK (2018) (0)
- A Retrospective Study of Progressive Gait Impairment in Alzheimer’s Disease (2022) (0)
- Synthesis and Evaluation of Two 18F-Labeled Imidazo[1,2-a]pyridine Analogues as Potential Agents for Imaging β-Amyloid in Alzheimer′s Disease. (2006) (0)
- P-003 An eight minute time limit increases sensitivity and improves clinical utility of the folstein mini mental state exam in african americans (2007) (0)
- DEVELOPING AN ELECTRONIC CONSENT FOR ADRC (2019) (0)
- Cerebrospinal Fluid beta-Amyloid 1-42 Solubility Is Influenced by Apolipoproteins E and J (S14.002) (2012) (0)
- Progressive white matter injury in autosomal dominant Alzheimer’s disease is strongly associated with cerebral microbleeds and neurodegeneration (2022) (0)
- KV1.3 INHIBITION REDUCES AB-INDUCED MICROGLIAL NEUROTOXICITY (2016) (0)
- P3-055 The role of specific vascular biomarkers on executive functioning in Alzheimer’s disease (2006) (0)
- Identifying novel causal genes and proteins in Alzheimer’s disease (2020) (0)
- ELUCIDATING THE RELATIONSHIP BETWEEN HYPERPHOSPHORYLATED TAU AND LOCUS COERULEUS DEGENERATION IN ALZHEIMER’S DISEASE (2016) (0)
- Medical Management of the Surgical Patient: Management of the surgical patient with dementia (2006) (0)
- P1-115 Characterization of PS1/APP mice deficient for the ApoE receptor sorLA/LR11 (2006) (0)
- DISTINCT BASELINE AND STRESS-INDUCED MAPK SIGNALING RESPONSES CHARACTERIZE MICROGLIA IN ALZHEIMER’S DISEASE MODELS (2019) (0)
- Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration (2020) (0)
- Differential Gene Expression in Microglial Polarized States and in Alzheimer’s Disease: Novel Insights Provided by Weighted Correlation Network Analysis (WGCNA) (P4.011) (2016) (0)
- LSD1 protects against hippocampal and cortical neurodegeneration (2017) (0)
- Advances in the molecular neurobiology of Alzheimerʼs disease (1992) (0)
- Diversity of mAChR heteroreceptor proteins in multiple hippocampal circuits (1997) (0)
- AGE RELATED CHANGES IN DOPAMINE TRANSPORTER IMMUNOREACTIVITY WITHIN THE HUMAN SUBSTANTIA NIGRA: AN UNBIASED STEREOLOGIC EVALUATION (1998) (0)
- Production of Antisera Using Fusion Proteins (1997) (0)
- Integrating multimodal data to support Alzheimer’s disease target prioritization (2021) (0)
- Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer’s disease (2017) (0)
- 41-1: Subtype-specific muscarinic cholinergic therapies in Alzheimer's disease (1997) (0)
- GenEpi: gene-based epistasis discovery using machine learning (2020) (0)
- The trend of disruption in the functional brain network topology of Alzheimer’s disease (2021) (0)
- LARGE-SCALE PROTEOMIC ANALYSIS OF HUMAN PREFRONTAL CORTEX IDENTIFIES PROTEINS ASSOCIATED WITH COGNITIVE TRAJECTORY IN ADVANCED AGE (2019) (0)
- INTEGRATIVE PROTEOMICS LINKS CEREBROSPINAL FLUID BIOMARKERS TO PATHOLOGICAL NETWORKS IN THE ALZHEIMER’S DISEASE BRAIN (2019) (0)
- The Collaboration and Harmonization of Digital Biomarkers for Alzheimer’s Research (2022) (0)
- Syddansk Universitet Variant ASGR1 associated with a reduced risk of coronary artery disease (2016) (0)
- Editorial Board (2007) (0)
- Complement Factor H is a Biomarker for Mild Cognitive Impairment Not Due to Alzheimer’s Disease (I11-1.006) (2014) (0)
- COMPREHENSIVE MAPPING OF ALZHEIMER’S DISEASE BRAIN UBIQUITYLOME (2018) (0)
- A CSF Signature of Frontotemporal Lobar Degeneration with C9orf72 Repeat Expansions (S18.003) (2014) (0)
- Use of specific antibodies for studying mGluR subtypes in rat brain (1996) (0)
- The Collaboration and Harmonization of Digital Biomarkers for Alzheimer’s Research (2022) (0)
- Pathologic Aggregates Of Small Nuclear Ribonucleoproteins (snRNP) Are Present In Familial Alzheimer's Disease (P1.244) (2014) (0)
- Gross Effects on the Nervous System References Cited (0)
- AD‐causing variants that affect PSEN1 transmembrane domains are associated with faster neurodegeneration and cognitive decline compared to those affecting cytoplasmic domains (2022) (0)
- Why We Need an Alzheimer's Moonshot in 2022 (2022) (0)
- Detection Of Increased Transcripts Of Human Endogenous Retrovirus In Plasma Of Patients With Frontotemporal Dementia Associated Amyotrophic Lateral Sclerosis (S40.004) (2014) (0)
- Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer’s disease (2020) (0)
- Guinea-pig tracheal parasympathetic nerves in primary culture express M2 muscarinic receptors (1995) (0)
- Deep learning-based polygenic risk analysis for Alzheimer’s disease prediction (2023) (0)
- Proteomics identifies CSF biomarker panels reflective of pathological networks in the Alzheimer's disease brain (2020) (0)
- Reply (2000) (0)
- Reply (1991) (0)
- P3-300 Effect of targeted domain deletions on LR11-mediated regulation of extracellular Aβ levels (2004) (0)
- The Emory‐Sage‐SGC TREAT‐AD Center: Tool and probe development for emerging targets in Alzheimer’s Disease (2022) (0)
- PRODUCTION OF MONOCLONAL ANTIBODIES REACTIVE AGAINST CHOLINE ACETYLTRANSFERASE AND THEIR APPLICATION FOR STUDYING CHOLINERGIC SYSTEMS. (1985) (0)
- Equity and Engagement for Neurologic Research Participation at the Goizueta Alzheimer’s Disease Research Center of Emory University (2022) (0)
- Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty (2017) (0)
- Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer’s disease (2018) (0)
- Proteomics Discovery of New Alzheimer’s Disease Targets (2015) (0)
- Effects of candesartan vs. lisinopril on neurocognitive functioning in executive mild cognitive impairment: The CALIBREX trial (2020) (0)
- Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer’s Dementia (2018) (0)
- THE CONSEQUENCES OF TAU IN THE LOCUS COERULEUS ON ALZHEIMER'S DISEASE (2018) (0)
- Multimodal magnetic resonance imaging reveals distinct sensitivity of hippocampal subfields in asymptomatic stage of Alzheimer’s disease (2022) (0)
- Rare sequence variants that disrupt ASGR 1 function lower non-HDL cholesterol and protect against coronary artery disease (2016) (0)
- Asparagine endopeptidase cleaves amyloid precursor protein and promotes amyloidogenesis in Alzheimer's disease (2015) (0)
- Operational criteria for patient recruitment in trials of mild cognitive impairment (2005) (0)
- Functional Analyses of Genetic Risk Variants of Depression-Related Phenotypes in the Human Brain (2020) (0)
- Abstract P021: Association of AHA Cardiovascular Health Metrics With Cognitive Function, Depression, and Anxiety: The Emory Healthy Aging Study (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Allan I. Levey?
Allan I. Levey is affiliated with the following schools: